Fastenal Shares Acquired by Chemical Bank

August 29, 2019

article image
Chemical Bank boosted its stake in shares of Fastenal (NASDAQ:FAST) by 170.3% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 29,862 shares of the company’s stock after purchasing an additional 18,814 shares during the period. Chemical Bank’s holdings in Fastenal were worth $973,000 at the end of the most recent quarter. A number of other institutional investors and hedge funds also recently made changes to their positions in FAST. Farmers & Merchants Investments Inc. increased its holdings in shares of Fastenal by 94.0% in the 2nd quarter. Farmers & Merchants Investments Inc. now owns 774 shares of the company’s stock worth $25,000 after purchasing an additional 375 shares in the last quarter. Investors Research Corp purchased a new position in Fastenal during the first quarter worth approximately $26,000. Clarus Wealth Advisors raised its stake in Fastenal by 101.2% during the second quarter.

Spotlight

Neurocrine Biosciences

Neurocrine Biosciences, Inc of San Diego is a product-based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. The Company's research and development efforts are focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders. We are committed to bringing new innovative treatments through development to deliver new hope to patients and their loved ones.

OTHER ARTICLES

Transporting biological and chemical materials - what you need to know

Article | February 13, 2020

The landscape of biological and chemical logistics has changed rapidly - as have the regulatory frameworks around it. What has not necessarily kept pace is the end-user understanding of the nature of these logistical processes, their opportunities and their constraints. Twenty years ago, the transmission of biological and chemical materials was limited to a small range of organisations: usually national and international research companies, hospitals, major university departments, police and military departments with forensic responsibilities.

Read More

Setting record straight on testing harm in chemicals

Article | February 13, 2020

The modern world is built on chemicals, be it the medicines we use, or cleaning fluids, crop protection products, or the raw materials for everything from laptops and mobile phones to clothes and furniture. Across all, we have created an entire modern society with chemicals, and, as a result, constantly stretched the size of the world population we can feed, clothe and shelter. Yet, balancing all the gains from the modern chemistry around us against any negative environmental and human impact has been a rising concern, making for ever greater focus on testing and on risk assessment.

Read More

Why chemical characterization is the best way to assess patient risk

Article | February 11, 2020

Everyone is very familiar with the phrase when buying a house: All that really matters are three things - location, location, and location. This same principle applies to extractables and leachables chemistry analysis – the three things that truly matter are identification, identification, and identification. The greatest growth in the past ten years in demonstrating the safety of medical devices and container closure systems for drugs has been using analytical chemistry to determine what chemicals can leach from the device and what the patient is exposed to during its intended use.

Read More

How Chemical Companies Benefit from the Experience Economy

Article | February 10, 2020

To feel or experience from a business engagement started with customer experience mainly in the consumer products business. Today it has extended to even knowledge industries like the chemical industry where experiencing or feeling can be leveraged to include all stake holders from customers primarily to employees to supply chain people & suppliers and all else. With digital technologies this has become easier than before. The benefits from promoting the ‘feel’ or ‘experience’ emotion could be multifarious for the chemical industry as described in this article.

Read More

Spotlight

Neurocrine Biosciences

Neurocrine Biosciences, Inc of San Diego is a product-based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. The Company's research and development efforts are focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders. We are committed to bringing new innovative treatments through development to deliver new hope to patients and their loved ones.

Events